NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Diabetes and Metabolism > Diabetes screening could happen at home

Diabetes screening could happen at home

16 January 2013 · Listed under Diabetes and Metabolism

Research led by the University of Oxford has found that people may be able to test themselves for diabetes in the comfort of their own home, using a novel electronic screening device.

The device was trialled in both healthy volunteers and people with diabetes, both in the home and in the clinic.

The study found the device was popular, easy to use, and did not require any special training. This suggests it could be used to help screen people for diabetes in the community and researchers hope that may increase the number of people who are screened.

Published online in the journal Diabetes Care, the study was carried out by the Diabetes Trials Unit’s Translational Research Group (TRG) – a group supported by the NIHR Oxford Biomedical Research Centre.

Nearly three million people have diabetes in the UK, but  many more may be unaware they have the condition.

Dr Angelyn Bethel, DTU Deputy Director and lead researcher on the study said: “Currently, doctors offer blood test screening to people who are thought to be at high risk of developing diabetes according to established risk factors like age or having a close relative who has diabetes.

“But this still requires people to come to a clinic or hospital with laboratory facilities to take the test.  This new device would allow the initial screening test to be done at home, and only those most likely to have diabetes or pre-diabetes – the condition that leads to diabetes – would need to see their GP for confirmation.”

“People taking part in our trial liked the option to test at home rather than having to go to their doctors’ surgery.  That added convenience might encourage more people to undergo screening,” continues Dr Bethel.

“A device like this has good potential as a research tool to help us find people eligible to take part in diabetes research studies, or could be used in parts of the world where access to laboratory facilities and skilled health care personnel are not available or the tests are too expensive,” she continues.  “The prototype device tested lacked the necessary accuracy, but once this is corrected, our study shows that home diabetes screening could become a real possibility.”

James Jackson, CEO of SmartSensor telemed, the company who developed the test kit, said: “The test kit used in this study is designed to be accessible, convenient and easy-to use for patients, and cost-effective for healthcare providers. Following this study, we have substantially refined the device and expect it to be on the market in the second half of 2013.”

The research was funded by Novartis Pharma AG.

← Video encourages patients to participate in diabetes trial
National award for project providing better care for women with diabetes during pregnancy →

News

  • Environmental impact of 57,000 multi-ingredient processed foods revealed for first time 9 August 2022
  • £1.2m award to improve diagnosis of emergency spinal condition 4 August 2022
  • Workshop helps public contributors become ‘citizen experts’ on equality and diversity in research 4 August 2022
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre